tiprankstipranks

Andrew Hirsch Insider Profile

4 Followers
Andrew Hirsch, PRESIDENT & CEO, Director at DNIB Unwind, Inc., holds 221.86K shares in C4 Therapeutics (Ticker: CCCC), holds 24.27K shares in Agios Pharma (Ticker: AGIO), holds ― shares in Editas Medicine (Ticker: EDIT).
tipranks
Andrew Hirsch

Andrew Hirsch
DNIB Unwind, Inc. (BINDQ)
PRESIDENT & CEO, Director

Not Ranked
Andrew Hirsch has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$2M
60.24%
39.76%
0.00%
A breakdown of Andrew Hirsch's holdings

Insider Roles

Agios Pharma
(AGIO)
CFO
C4 Therapeutics
(CCCC)
President & CEO, Director
Editas Medicine
(EDIT)
Director
Roles that Andrew Hirsch holds in companies

Most Profitable Insider Trade

Stock:
C4 Therapeutics
(CCCC)
Rating:Informative Buy
Date:Apr 12, 2022 - Apr 12, 2023
Return:-64.30%
The most profitable trade made by Andrew Hirsch

Andrew Hirsch's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
BINDQ
DNIB Unwind, Inc.
Sep 19, 2013
Uninformative Buy
$4.54K
Agios Pharma
Apr 24, 2020
CFO
Uninformative Buy
182.08K
$1.35M
Editas Medicine
May 31, 2017
Director
Uninformative Buy
C4 Therapeutics
Nov 12, 2024
President & CEO, Director
Uninformative Buy
41.98K
$889.67K
List of latest transactions for each holding click on a transaction to see Andrew Hirsch's performance on stock

Andrew Hirsch insider profile FAQ

What is the percentage of profitable transactions made by Andrew Hirsch?
The percentage of profitable transactions made by Andrew Hirsch is ―.
    What is the average return per transaction made by Andrew Hirsch?
    The average return per transaction made by Andrew Hirsch is ―.
      What stocks does Andrew Hirsch hold?
      Andrew Hirsch holds: BINDQ, AGIO, EDIT, CCCC stocks.
        What was Andrew Hirsch’s latest transaction?
        Andrew Hirsch latest transaction was an Uninformative Buy of $41.98K.
          What was Andrew Hirsch's most profitable transaction?
          Andrew Hirsch’s most profitable transaction was an Informative Buy of CCCC stock on April 12, 2022. The return on the trade was -64.30%.
            What is Andrew Hirsch's role in DNIB Unwind, Inc.?
            Andrew Hirsch's role in DNIB Unwind, Inc. is PRESIDENT & CEO, Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.